Join our experts who will be covering the burning platform that is early stage drug development, listen and ask them questions on their thoughts on the role of Medical Affairs in early-stage drug development.
Here, we explore the application of the SCARF (status, certainty, autonomy, relatedness, and fairness) model, learned helplessness, and locus of control to the assessment of impact in the pharmaceutical industry and describe approaches by which hesitancy can be overcome.
Discover how Agnetic is harnessing AI to revolutionize healthcare, unlocking powerful medical insights for better, faster, and more personalized care.
The session will walk attendees through how pillars of impact—Impact Story, Contributions, and Execution—were used to translate high-level strategy into tangible action.
This article addresses the metrics that Medical Affairs can use to measure how effectively they communicate on their strategic imperatives, with a specific focus on Share of Scientific Voice (SoSV).
In this On-Demand webinar, we explore the recently released MAPS Standards & Guidance (S+G) documents, “Measuring Value and Impact in Medical Affairs” and “Strategic Medical Planning Guide.”
In this On-Demand webinar, we will provide attendees with perspectives on these important questions from industry leaders across functions, including Commercial, Marketing, Market Access and R&D, and practical advice on how to master the art of collaboration to improve cohesion for collective success.